Science Stock Valuation

SSAA
 Stock
  

USD 9.87  0.03  0.30%   

Do you wonder what the value of Science Strategic is? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Science Strategic, is its stock price multiplied by the total number of shares outstanding, calculating Science Strategic's enterprise value requires a different approach. It uses Science Strategic's balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
Science Strategic has a current Real Value of $9.66 per share. The regular price of the company is $9.87. At this time, the company appears to be fairly valued. Our model measures the value of Science Strategic from inspecting the company fundamentals such as Return On Asset of (1.18) %, price to earning of 140.14 X, and Shares Owned by Institutions of 85.60 % as well as reviewing its technical indicators and Probability Of Bankruptcy. In general, we recommend taking in undervalued stocks and trading overvalued stocks since, at some point, asset prices and their ongoing real values will draw towards each other.
  
Science Strategic Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Science Strategic's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.

Science Most Recent Valuation Data

Price Book
1.3
Enterprise Value
383.9 M
Enterprise Value Ebitda
-139.73
Trailing PE
141.0
Fairly Valued
Today 9.87
Please note that Science Strategic's price fluctuation is very steady at this time. Calculation of the real value of Science Strategic is based on 3 months time horizon. Increasing Science Strategic's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Science Strategic Acquisition is useful when determining the fair value of the Science stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Science Strategic. Since Science Strategic is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Science Stock. However, Science Strategic's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
9.66
Real Value
10.86
Upside
Estimating the potential upside or downside of Science Strategic Acquisition helps investors to forecast how Science stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Science Strategic more accurately as focusing exclusively on Science Strategic's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
9.799.859.90
Details
Hype
Prediction
LowEstimated ValueHigh
9.709.8710.04
Details
Naive
Forecast
LowNext ValueHigh
9.709.8710.04
Details

Science Strategic Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Science Strategic's current stock value. Our valuation model uses many indicators to compare Science Strategic value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Science Strategic competition to find correlations between indicators driving Science Strategic's intrinsic value. More Info.
Science Strategic Acquisition is currently regarded as top stock in price to earning category among related companies. It is currently regarded as top stock in price to book category among related companies fabricating about  0.54  of Price to Book per Price to Earning. The ratio of Price to Earning to Price to Book for Science Strategic Acquisition is roughly  1.86 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Science Strategic by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Science Strategic's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Science Strategic's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Science Strategic's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Science Strategic and how it compares across the competition.

About Science Strategic Valuation

The equity valuation mechanism determines the current worth of Science Strategic Acquisition on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Science Strategic Acquisition. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Science Strategic based exclusively on its fundamental and basic technical indicators. By analyzing Science Strategic's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Science Strategic's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Science Strategic. We calculate exposure to Science Strategic's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Science Strategic's related companies.
Fiscal Year End
December
Industry
Shell Companies
It focuses on effecting a merger, share exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses in the direct-to-consumer brands, D2C services, and mobile and social entertainment sectors. The company was incorporated in 2020 and is based in Santa Monica, California. Science Strategic is traded on NASDAQ Exchange in the United States.

Science Strategic Valuation Growth Rates

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Science Strategic does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Quick Ratio0.18
Earnings Quarterly Growth203.10%
Earnings Growth123.30%
Additionally, take a look at World Market Map. Note that the Science Strategic information on this page should be used as a complementary analysis to other Science Strategic's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Complementary Tools for Science Stock analysis

When running Science Strategic price analysis, check to measure Science Strategic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Science Strategic is operating at the current time. Most of Science Strategic's value examination focuses on studying past and present price action to predict the probability of Science Strategic's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Science Strategic's price. Additionally, you may evaluate how the addition of Science Strategic to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Is Science Strategic's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Science Strategic. If investors know Science will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Science Strategic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
1.23
Market Capitalization
381.9 M
Return On Assets
-0.0118
The market value of Science Strategic is measured differently than its book value, which is the value of Science that is recorded on the company's balance sheet. Investors also form their own opinion of Science Strategic's value that differs from its market value or its book value, called intrinsic value, which is Science Strategic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Science Strategic's market value can be influenced by many factors that don't directly affect Science Strategic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Science Strategic's value and its price as these two are different measures arrived at by different means. Investors typically determine Science Strategic value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Science Strategic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.